Idelalisib monotherapy and durable responses in patients with relapsed or refractory marginal zone lymphoma (MZL)

被引：0
|
作者：
Martin, P. [1 ]
Armas, A. [2 ]
Gopal, A. [3 ]
Gyan, E. [4 ]
Wagner-Johnston, N. [5 ]
Walewski, J. [6 ]
Abella, S. [7 ]
Ye, W. [7 ]
Philip, B. [7 ]
Sorenson, B. [7 ]
de Vos, S. [8 ]
机构：
[1] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA
[2] Calaway Young Canc Ctr, Glenwood Springs, CO USA
[3] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA
[4] Ctr Hosp Univ, Serv Hematol & Therapie Cellulaire, Tours, France
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[6] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Lymphoproliferat Dis, Warsaw, Poland
[7] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
241
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL)
    Martin, Peter
    Armas, Armando
    Gopal, Ajay K.
    Gyan, Emmanuel
    Wagner-Johnston, Nina D.
    Walewski, Jan
    Abella, Steve
    Ye, Wei
    Philip, Betsy
    Sorenson, Bess
    de Vos, Sven
    [J]. BLOOD, 2015, 126 (23)
  • [2] DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA (MZL)
    Gyan, E.
    Martin, P.
    Armas, A.
    Gopal, A. K.
    Wagner-Johnston, N. D.
    Abella-Dominicis, E.
    Ye, W.
    Philip, B.
    Sorenson, B.
    Walewski, J.
    de Vos, S.
    [J]. HAEMATOLOGICA, 2016, 101 : 757 - 758
  • [3] DURABLE RESPONSES WITH IDELALISIB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY SMALL LYMPHOCYTIC LYMPHOMA (SLL)
    Davies, A. J.
    Gopal, A. K.
    Flinn, I. W.
    Ghia, P.
    Goy, A.
    Abella-Dominicis, E.
    Philip, B.
    Sorenson, B.
    Salles, G. A.
    Wagner-Johnston, N. D.
    [J]. HAEMATOLOGICA, 2016, 101 : 757 - 757
  • [4] Idelalisib monotherapy and durable responses in patients with relapsed or refractory small lymphocytic lymphoma (SLL)
    Gopal, A.
    Davies, A. J.
    Flinn, I.
    Ghia, P.
    Goy, A.
    Salles, G.
    Abella, S.
    Philip, B.
    Sorenson, B.
    Wagner-Johnston, N.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 102 - 102
  • [5] Idelalisib Monotherapy and Durable Responses in Patients with Relapsed or Refractory Small Lymphocytic Lymphoma (SLL)
    Gopal, Ajay K.
    Davies, Andrew John
    Flinn, Ian W.
    Ghia, Paolo
    Goy, Andre
    Salles, Gilles A.
    Abella, Steve
    Philip, Betsy
    Sorenson, Bess
    Wagner-Johnston, Nina D.
    [J]. BLOOD, 2015, 126 (23)
  • [6] Idelalisib monotherapy and durable responses in patients with relapsed or refractory Waldenstroms Macroglobulinemia (WM)
    Coutre, Steven
    Leonard, John
    Flowers, Christopher
    Davies, Andrew John
    Jurczak, Wojciech
    Byrd, John C.
    Spurgeon, Stephen Edward Forbes
    Peterman, Sissy
    Holes, Leanne
    Cho, Yoonjin
    Sorenson, Bess
    Godfrey, Wayne Russell
    Gopal, Ajay K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM MACROGLOBULINEMIA
    Zinzani, P. L.
    Ghia, P.
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J. C.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorensen, B.
    Godfrey, W. R.
    Gopal, A. K.
    Carella, A. M.
    [J]. HAEMATOLOGICA, 2015, 100 : 38 - 39
  • [8] Idelalisib monotherapy results in durable responses in patients with relapsed or refractory Waldenstrom's macroglobulinemia (WM)
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorenson, B.
    Godfrey, W.
    Gopal, A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 102 - 102
  • [9] IDELALISIB MONOTHERAPY RESULTS IN DURABLE RESPONSES IN PATIENTS WITH RELAPSED OR REFRACTORY WALDENSTROM'S MACROGLOBULINEMIA (WM)
    Coutre, S.
    Leonard, J.
    Flowers, C.
    Davies, A.
    Jurczak, W.
    Byrd, J.
    Spurgeon, S.
    Peterman, S.
    Holes, L.
    Cho, Y.
    Sorenson, B.
    Godfrey, W.
    Gopal, A.
    [J]. HAEMATOLOGICA, 2015, 100 : 273 - 273
  • [10] Zanubrutinib in patients with relapsed/refractory marginal zone lymphoma (MZL): Final analysis of MAGNOLIA (BGB-3111-214)
    Linton, Kim M.
    Trotman, Judith
    Mckay, Pamela
    Ardeshna, Kirit
    Iyengar, Sunil
    Tedeschi, Alessandra
    Hu, Bei
    Leitch, Sophie
    Jin, Jie
    Sun, Mingyuan
    Sobieraj-Teague, Magdalena
    Zinzani, Pier Luigi
    Browett, Peter
    Ke, Xiaoyan
    Portell, Craig A.
    Thieblemont, Catherine
    Bijou, Fontanet
    Walker, Patricia
    Hawkes, Eliza A.
    Ho, Shir-Jing
    Zhou, Keshu
    Liang, Zhiyu
    Xu, Jianfeng
    Tankersley, Chris
    Delarue, Richard
    Co, Melannie
    Opat, Stephen
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 12 - 12
12345